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Abstract
The sensing of nucleic acids by receptors of the innate immune
system is a key component of antimicrobial immunity. RNA:DNA
hybrids, as essential intracellular replication intermediates gener-
ated during infection, could therefore represent a class of previ-
ously uncharacterised pathogen-associated molecular patterns
sensed by pattern recognition receptors. Here we establish that
RNA:DNA hybrids containing viral-derived sequences efficiently
induce pro-inflammatory cytokine and antiviral type I interferon
production in dendritic cells. We demonstrate that MyD88-
dependent signalling is essential for this cytokine response and
identify TLR9 as a specific sensor of RNA:DNA hybrids. Hybrids
therefore represent a novel molecular pattern sensed by the
innate immune system and so could play an important role in host
response to viruses and the pathogenesis of autoimmune disease.
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Introduction
The innate immune system is a key component of host response to
infection. It senses molecular patterns associated with pathogens and
“danger” using a repertoire of germline-encoded pattern recognition
receptors (PRRs) that permit detection of conserved microbial
molecular motifs (Matzinger, 1994; Janeway & Medzhitov, 2002).
Nucleic acids, as indispensable components of all pathogens, represent
an important class of PRR ligand (Barbalat et al, 2011). Several fami-
lies of nucleic acid-sensing PRRs have been characterised, including
the membrane-associated Toll-like receptor (TLR) and cytosolic RNA-
sensing RIG-I-like receptor (RLR) families (Desmet & Ishii, 2012).
Five TLRs sense nucleic acids: TLR3 (double-stranded RNA,
dsRNA), TLR7/8 (single-stranded RNA, ssRNA), TLR9 (bacterial
DNA) and TLR13 (23S rRNA) (Hemmi et al, 2000; Alexopoulou
et al, 2001; Diebold et al, 2004; Heil et al, 2004; Oldenburg et al,
2012). These TLRs localise to intracellular membranes, relocating
from the ER to endolysosomes via UNC93B1-mediated trafficking
(Latz et al, 2004; Kim et al, 2008), where they undergo proteolytic
cleavage to generate a functional receptor that interacts with its
nucleic acid ligand (Ewald et al, 2008; Park et al, 2008). Nucleic
acid binding to TLR homodimers recruits the adapter proteins TRIF
or MyD88 to trigger NF-jB and/or IRF signalling pathways, inducing
pro-inflammatory cytokines and type I interferon (IFN) respectively
(Blasius & Beutler, 2010).
Viral genomes (Lund et al, 2003; Rehwinkel et al, 2010) and their
replication intermediates (Lee et al, 2007) are detected as non-self
nucleic acids in cytosolic and endosomal compartments by PRRs,
which induce type I IFN production to establish a potent antiviral
response (Samuel, 2001). In some circumstances, the same receptors
bind self-nucleic acids, such as those released from damaged cells
(Pisetsky & Fairhurst, 2007). This can occur when self-nucleic acids
in complex with human cationic host defence peptides such as LL-37
are internalised by antigen presenting cells (APCs) which potently
activate PRR signalling cascades and type I IFN production (Lande
et al, 2007; Ganguly et al, 2009). An inflammatory response in the
absence of infection also occurs in the childhood onset single gene
disorder Aicardi-Goutieres syndrome (AGS)(Crow & Livingston,
2008). This genetic mimic of viral infection is caused by mutations in
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genes encoding four nucleic acid-metabolising enzymes, including
Ribonuclease (RNase) H2 (Crow et al, 2006b). As RNase H enzymes
hydrolyse the RNA strand of RNA:DNA heteroduplexes (Stein &
Hausen, 1969), RNA:DNA hybrids are thought to accumulate in
RNase H2-deficient AGS patient cells and induce type I IFN through
PRR activation (Alarcon-Riquelme, 2006). Physiological sensing of
RNA:DNA hybrids may also be immunologically advantageous, as
many major pathogenic viruses (including HIV, CMV, EBV and
Hepatitis B) generate RNA:DNA hybrid structures during their
replication within an infected cell (Summers & Mason, 1982;
Prichard et al, 1998; Rennekamp & Lieberman, 2011).
Given the essential role of RNA:DNA hybrids in retroviral replica-
tion and the postulated accumulation of RNA:DNA hybrids in AGS,
we hypothesised that RNA:DNA hybrids may represent an additional
category of immunostimulatory nucleic acid species. Here we
demonstrate that intracellular targeting of these molecules elicits an
innate immune response and define viral-related RNA:DNA hybrid
sequences that are sensed by both plasmacytoid and conventional
dendritic cells (DCs). Finally, we identify MyD88 and TLR9 as the
signalling adaptor and sensor required for this response, thereby estab-
lishing RNA:DNA hybrids as novel high-affinity ligands for TLR9.
Results
Synthesis and purification of RNA:DNA hybrids with viral
sequence motifs
To address whether RNA:DNA hybrids represent a novel class of
molecular pattern sensed by PRRs, we generated a synthetic 60-bp
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Figure 1. Generation of purified RNA:DNA hybrids.
A Schematic representation of the synthesis and purification of the 60-bp RNA:DNA hybrid R:D60. Equimolar amounts of single-stranded RNA and DNA
oligonucleotides were heat-denatured and gradually cooled to form RNA:DNA hybrids. Contaminating nucleic acids were removed by size-exclusion FPLC.
B Annealing of ssDNA60 and ssRNA60 oligonucleotides generates a 60-bp RNA:DNA hybrid with low levels of contaminating nucleic acid by-products. Native PAGE
analysis of 100 ng of each single-stranded oligonucleotide prior to hybridisation and 200 ng post-annealing. Contaminating nucleic acids are indicated by arrowheads.
C FPLC gel filtration separates R:D60 from contaminating nucleic acids. Top, OD280 readings of eluted fractions. Bottom, analysis of 100 ll of selected FPLC fractions
(peaks 1–4) by native PAGE. Contaminating nucleic acids are indicated by arrowheads.
D FPLC-purified R:D60 is free from contaminating nucleic acids. Native PAGE analysis of concentrated R:D60 from peak 3 fractions alongside single-stranded
constituent oligonucleotides.
E Purified R:D60 is an RNA:DNA hybrid as demonstrated by immunoblotting with an RNA:DNA hybrid-specific antibody. Immunoblotting with the S9.6 monoclonal
antibody detects intact R:D60 but not R:D60 that has been enzymatically digested by the RNA:DNA hybrid-specific enzyme RNase H1.
F Native PAGE analysis is sensitive enough to detect ≤ 1% ssDNA and ≤ 2.5% (w/w) ssRNA within the purified R:D60 hybrid.
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hybrid containing a repetitive guanosine-uridine-(GU) RNA strand
motif (Fig 1A), on the basis that GU-rich viral RNA sequences are
established nucleic acid ligands (Diebold et al, 2004; Heil et al,
2004). Chemically-synthesised oligonucleotides were annealed to
form a 60-bp duplex (“R:D60”) and hybridrisation confirmed by
native polyacrylamide gel electrophoresis (PAGE) analysis (Fig 1B).
However, low levels of contaminating nucleic acid species were also
evident, including one with identical electrophoretic mobility to the
constituent DNA oligonucleotide (ssDNA60) and also a high-
molecular-weight species, likely to represent a multimeric form of
the hybrid (Fig 1B, arrowheads). Fast performance liquid chroma-
tography (FPLC) was used to remove the potentially immunostimu-
latory by-products by size-exclusion fractionation (Fig 1C). This
resulted in a pure nucleic acid species of 60 bp (Fig 1D), which was
confirmed to be an RNA:DNA hybrid by immunoblotting with the
RNA:DNA hybrid-specific S9.6 monoclonal antibody (Boguslawski
et al, 1986) and enzymatically by exhibiting sensitivity to RNase H
(Fig 1E). Additional nucleic acid species were undetectable by PAGE
analysis (Fig 1F), establishing that the purity of R:D60 was
≥ 97.5%, given that 1% ssDNA and 2.5% (w/w) ssRNA could be
visualised by this method. Using this strategy, sufficient R:D60 was
then purified for subsequent experiments to investigate whether
RNA:DNA hybrids stimulate an innate immune response.
Dendritic cells are phenotypically activated and secrete
cytokines in response to intracellular RNA:DNA hybrids
Nucleic acid-sensing PRRs of the innate immune system are widely
expressed across a range of cell types, including non-immune cells
such as fibroblasts. Therefore R:D60 was initially transfected into
primary mouse embryonic fibroblasts (MEFs). However, this failed
to induce the expression of genes encoding type I IFNs, in contrast
to the robust response induced by the TLR3 ligand poly(I:C) and
the TLR9 ligand CpG ODN (ODN1585, Type A CpG ODN) (Supple-
mentary Fig S1A). This led us to consider whether the detection of
RNA:DNA hybrids might be restricted to specialised APCs. Trans-
fection of R:D60 into bone-marrow derived macrophages (BMDMs)
failed to induce the secretion of a range of cytokines by these cells,
including IFN-a, IL-6 and TNF-a (Supplementary Fig S1B). In con-
trast, transfection of R:D60 into Fms-like tyrosine kinase 3-ligand
(Flt-3)-differentiated bone marrow-derived dendritic cells (FLDCs)
resulted in substantial production of IL-6 (P = 0.0010), IFN-a
(P = 0.0156) and TNF-a (P = 0.0458) (Fig 2A). To confirm that
viral RNA:DNA hybrids were immunostimulatory, we generated a
second RNA:DNA hybrid containing 45 bp of the HIV-1 group-
associated antigen (gag) gene (“R:D45”) (Supplementary Fig S2).
Transfection of this hybrid into FLDCs also induced a substantial
inflammatory cytokine response, comparable to that stimulated by
R:D60 (Fig 2B).
FLDCs are a heterogeneous population that can be subdivided
into conventional DC (cDC) and plasmacytoid DC (pDC) popula-
tions by surface expression of B220/CD45R (Brasel et al, 2000;
Brawand et al, 2002), which differentially sense viral nucleic acids
(Kato et al, 2005). We therefore investigated which DC subtype was
responding to RNA:DNA hybrids. Transfection of R:D60 into FLDCs
induced phenotypic activation of both FACS-purified pDC (CD11c+
B220+) and cDC (CD11c+ B220) populations, as determined by
upregulated surface expression of the costimulatory molecules
CD40, CD80 and CD86 (Fig 2C, D). Next, we sought to determine
which subset of FLDCs was responsible for the cytokine response to
intracellular R:D60, as phenotypic activation can occur in the
absence of cytokine production. FLDCs were sorted into pDC
(CD11c+ B220+ PDCA-1+) and cDC (CD11c+ B220 PDCA-1)
populations by flow cytometry and transfected with R:D60. This
induced a pro-inflammatory cytokine response (IL-6) exclusively in
cDCs (Fig 2E, left panel) whereas type I IFN (IFN-a) was produced
solely by pDCs (Fig 2E, right panel).
The complexing of R:D60 with a liposomal transfection reagent
(Lipofectamine) was essential for cytokine production, in keeping
with intracellular detection or RNA:DNA hybrids by PRRs (Fig 2A).
LL-37, a naturally occurring inflammatory product of neutrophils,
epithelial cells and macrophages (Beaumont, 2013), is known to
bind and internalise nucleic acids into mammalian cells (Sandgren
et al, 2004; Lande et al, 2007; Ganguly et al, 2009; Lai et al, 2011).
Internalisation of R:D45 using LL-37 but not a scrambled peptide
control (scLL37) was also able to induce cytokine production and
activation of FLDCs (Fig 2F).
We therefore concluded that intracellular RNA:DNA hybrids
induce cytokine secretion and phenotypic activation of dendritic
cells in vitro.
Figure 2. Intracellular RNA:DNA hybrids induce cytokine production and activation of dendritic cells.
A Transfection of R:D60 into FLDCs stimulates IL-6, IFN-a and TNF-a secretion. Bone marrow-derived FLDC cultures were transfected with R:D60 complexed with
Lipofectamine LTX. Supernatant cytokine levels were quantified 18 h later by ELISA. Data shown are the mean of at least five independent experiments  s.e.m.
***P = 0.001023 (IL-6), *P = 0.015561 (IFN-a), *P = 0.45789
B Stimulation of cytokine production in FLDCs by a 45-bp RNA:DNA hybrid containing sequence from the HIV-1 gag gene. FLDCs were transfected with R:D45 or
R:D60 using Lipofectamine LTX. Data shown are from four independent experiments  s.e.m.; *P = 0.0122 (IL-6), *P = 0.0201 (IFN-a).
C, D R:D60 induces phenotypic activation of FLDCs. Unsorted FLDC cultures were stimulated with R:D60 as described for (A). Expression levels of the co-stimulatory
molecules CD40, CD80 and CD86 on CD11c+ B220+ pDCs (C) and CD11c+ B220 cDCs (D) were quantified by flow cytometry. Below, median fluorescence intensity
(MFI) values for CD40 and CD86 from six independent experiments  s.e.m.; ***P = 0.000003 (pDCs CD86), ***P = 0.0001 (pDCs CD40), ***P = 0.00009 (cDCs
CD40), ***P = 0.000000003 (cDCs CD86). CpG ODN added to the culture medium was included as a control. (CpG A could be added to cultures without
complexing to Lipofectamine, as it generates large macromolecular aggregates due to unusual self-aggregating properties, sufficient to stimulate spontaneous
cellular uptake (Wu et al 2004)).
E R:D60 stimulates IL-6 secretion by cDCs and IFN-a production by pDCs. Day 8-FLDC cultures were sorted into CD11c+ B220+ PDCA1+ (pDC) and CD11c+ B220
PDCA1 (cDC) populations and stimulated as described for (C) and (D). Cytokine concentrations were quantified 18 h later by ELISA. Data shown are from three
(IL-6) or four (IFN-a) independent experiments  s.e.m.
F R:D45 delivered into the cell by LL-37 stimulates cytokine production and phenotypic activation of FLDCs. 1 lg/ml R:D45 complexed with 25 lg/ml LL-37 or
scrambled LL-37 (scLL-37) peptide was added to the medium of FLDC cultures. Supernatant cytokine levels and expression of co-stimulatory molecules were
determined. Data shown are representative of three independent experiments  s.e.m. (n = 3 replicates); **P = 0.0025 (CD86), **P = 0.0090 (IL-6).
▸
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Intracellular targeting of RNA:DNA hybrids stimulates cytokine
secretion in vivo in mice and ex vivo in human PBMCs
As FLDC cultures represent an in vitro model of steady-state splenic
DC populations (Brawand et al, 2002; Naik et al, 2005) we next
investigated whether RNA:DNA hybrids could be detected by
splenic DCs in vivo. R:D45 was injected intraperitoneally into
C57BL/6 mice either alone or complexed to the cationic liposome
Invivofectamine. Analysis of splenic DC populations 12 h post injec-
tion by flow cytometry showed a significant upregulation of CD40,
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CD80 and CD86 expression by cDCs and pDCs when the hybrid was
administered in a liposomal complex (Fig 3A). A comparable level
of activation was seen between cDC subsets (Supplementary Fig
S3). Furthermore, R:D45 complexed to Invivofectamine induced a
robust cytokine response, with significantly elevated levels of both
IL-6 and IFN-a in the serum of these mice (Fig 3B). Consistent with
in vitro FLDC experiments, liposomal delivery was essential for
RNA:DNA hybrid stimulation for cytokine secretion and DC
activation (Fig 3A, B).
To investigate whether RNA:DNA hybrids were also able
to induce a cytokine response in human cells, we used ex vivo
peripheral blood mononuclear cells (PBMCs) that comprise a mixed
population of cells including lymphocytes, monocytes, cDCs and
pDCs. Transfection with R:D45 induced significant production of
both IL-6 and IFN-a by PBMCs (Fig 3C), establishing that the innate
immune sensing of RNA:DNA hybrids is not species-specific.
In summary we concluded that the detection of RNA:DNA
hybrids within an intracellular compartment occurs in mice (in vivo)
and in humans (ex vivo). Consequently, we next sought to identify
the cellular pathway involved in the sensing of RNA:DNA hybrids.
MyD88 is essential for FLDC activation by RNA:DNA hybrids
Many nucleic acid-sensing PRRs require the binding of an adaptor
molecule to mediate downstream signalling and subsequent
cytokine production. To identify the PRR-adaptor pathways
sensing RNA:DNA hybrids, FLDCs derived from mice lacking the
adaptor proteins IPS-1, TRIF or MyD88 were transfected with R:
D60. The cytokine response of Ips-1/ FLDCs was indistinguish-
able from that of C57BL/6 control FLDCs, however R:D60-induced
production of both IL-6 and IFN-a was undetectable in cells from
mice lacking both the TRIF and MyD88 adaptor molecules (Fig 4A,
B). FLDCs deficient in MyD88 alone failed to produce cytokines in
response to R:D60 (Fig 4C), while cytokine production was intact
in Trif/ FLDCs (Supplementary Fig S4A). Similarly, phenotypic
activation of both pDCs and cDCs was abrogated in cells lacking
MyD88 (Fig 4D) but intact in Trif/ FLDCs (Supplementary Fig
S4B), thereby confirming that MyD88 is essential for downstream
signalling following PRR detection of RNA:DNA sensing in both
DC subtypes.
TLR9 senses RNA:DNA hybrids
Given that response to RNA:DNA hybrids was independent of TRIF,
TLR3 and the DDX1/DDX21/DHX36 complex (Yamamoto et al,
2002; Zhang et al, 2011) were ruled out as candidate sensors of
these hybrids. Likewise, the cytosolic RNA sensors RIG-I and MDA5
were excluded as both are dependent on binding to IPS-1 for down-
stream signalling (Kawai et al, 2005). However, TLR7 and TLR9
both require MyD88 for downstream signalling (Schnare et al, 2000;
Hemmi et al, 2002) and so represented strong candidates for the
intracellular sensor of RNA:DNA hybrids.
FLDCs derived from Tlr7/ and Tlr9/ mice were transfected
with R:D60. Production of both IL-6 and IFN-a was found to be
significantly reduced in Tlr9/ FLDCs (Fig 4E). Similarly, cytokine
production in response to R:D45 was undetectable (Fig 4G).
Conversely, Tlr7/ FLDCs displayed normal cytokine responses to
RNA:DNA hybrids (Fig 4F). Analysis of cytokine production in
FACS-sorted FLDCs confirmed that IL-6 production by TLR9-
deficient cDCs was completely abolished and IFN-a production by
pDCs significantly impaired (Fig 4H). Therefore, TLR9 appears to be
the sole RNA:DNA hybrid-sensing receptor in cDCs and represents
the major receptor for hybrids in pDCs. Residual IFN-a secretion by
Tlr9/ pDCs in response to R:D60 could suggest an additional
hybrid-sensing receptor in this cell type, in which case DHX9 or
DHX36 could be plausible candidates given that they have been
reported to be MyD88-dependent sensors (Kim et al, 2010).
Chloroquine treatment of wild-type C57BL/6 FLDCs also
impaired cytokine secretion following subsequent R:D60 transfec-
tion (Fig 4I). Since cholorquine is an established inhibitor of
endosomal TLR-nucleic acid binding (Hacker et al, 1998) this indi-
cated that hybrids activate TLR9 in an endosomal compartment.
Together, these data established that endosomal detection of
RNA:DNA hybrids by TLR9 leads to activation of downstream
signalling and cytokine production.
Intact RNA:DNA hybrids stimulate cytokine secretion by FLDCs
Single-stranded DNA (ssDNA) can potently activate TLR9-mediated
signalling (Hemmi et al, 2000), therefore the degradation of
RNA:DNA hybrids by intracellular RNase H enzymes to ssDNA
could provide an explanation for TLR9 activation by intracellular
RNA:DNA hybrids. To address this, we transfected equimolar
amounts of the constituent 60-mer single-stranded oligonucleotides
into FACS-sorted FLDC populations and measured cytokine produc-
tion. Transfection of the DNA strand (“ssDNA60”) resulted in the
production of only low levels of IL-6 by cDCs (Fig 5A) and no IFN-a
secretion by pDCs (Fig 5B). Therefore, ssDNA generated from the
enzymatic digestion of R:D60 is unlikely to be responsible for the
activation of TLR9-dependent signalling.
We also considered the possibility that internalised RNA:DNA
hybrids could be unwound by cytosolic helicases, generating ssRNA
in addition to ssDNA. Although transfection of the RNA strand
(“ssRNA60”) induced a robust cytokine response in FACS-sorted
cDCs and pDCs, the nature of this response differed from that
induced by R:D60; as it was restricted to pDCs (Fig 5A, B) and inde-
pendent of TLR9 (Fig 5C).
We therefore concluded that TLR9 senses intact RNA:DNA
hybrids without enzymatic processing or physical dissociation of
the heteroduplex, strongly suggesting that RNA:DNA hybrids
directly bind TLR9.
We then sought to confirm that cytokine production by FLDCs
was due to the RNA:DNA hybrids themselves, rather than it being
attributable to a contaminant introduced during synthesis or trans-
fection. Firstly, contamination of the Lipofectamine transfection
reagent was excluded as it did not induce cytokine production or
phenotypic activation of FLDCs (Fig 2). Secondly, in the absence of
transfection reagent, R:D60 was not immunogenic, thereby exclud-
ing endotoxin contamination in the hybrid preparation (Fig 2).
Thirdly, to exclude the possibility that low levels of single-stranded
nucleic acids present in the hybrid preparation below the sensitivity
of PAGE analysis could represent a source of contamination, the
FPLC process was repeated using “mock” hybridisation reactions in
which one of the constituent oligonucleotides (ssRNA60 or ssDNA60)
was omitted. Following FLPC, nucleic acids were not visualised in
the elution fractions from mock hybridisations, that usually would
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have contained the hybrid (Fig 5D, E). Furthermore, these fractions
were not immunostimulatory when transfected into FLDCs (Fig 5F).
Therefore, FLDC activation could not be attributed to the co-filtration
of non-visible contaminants in FPLC-purified R:D60.
To directly establish that RNA:DNA hybrids remained intact
within FLDCs, we fluorescently labelled 45-bp RNA:DNA hybrids
(R:D45) by conjugation of Cy5 and Cy3 fluorophores to the 5′ ends
of the ssRNA45 and ssDNA45 oligonucleotides, respectively. Visu-
alisation of the intracellular nucleic acids post-transfection using
confocal microscopy established that Cy3 and Cy5 signals remained
colocalised in all foci with equivalent intensity, consistent with the
R:D45 hybrid remaining intact within the cell (Fig 6A, yellow foci).
As a control, the non-complementary oligonucleotides Cy3-ssRNA45
and Cy5-ssDNA60 were “annealed” in the same manner and trans-
fected into FLDCs. In this case Cy3 and Cy5 signals did not show the
same level of colocalisation (Fig 6B), with only 9% of foci showing
similar intensity Cy3 and Cy5 signals, suggesting a random
distribution of non-hybridised oligonucleotides in intracellular foci
(Fig 6B, C). Furthermore, immunostaining with the S9.6 antibody
also detected fluorescently labelled R:D45 foci, confirming that these
represent intact intracellular RNA:DNA hybrids (Fig 6D).
As Lipofectamine-mediated uptake of nucleic acid-liposomal
complexes initially occurs via endocytosis (Akita et al, 2004) we
also examined whether fluorescently labelled R:D45 could colocalise
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Figure 3. R:D45 activates DCs and induce a systemic cytokine response in vivo in mice and ex vivo in human cells.
A Delivery of R:D45 complexed to Invivofectamine in vivo phenotypically activates DCs. C57BL/6 mice were injected intraperitoneally with 80 lg R:D45 or 80 lg R:D45
complexed to Invivofectamine and the activation of splenic DC populations was analysed 12 h later by flow cytometry. Left, representative histograms comparing
cell surface expression of the indicated marker on DCs from mice treated with Invivofectamine alone (grey) and R:D45 complexed to Invivofectamine (black). Isotype
control shaded grey. Right, MFI values for CD40 (P = 0.0000013), CD80 (P = 0.000106) and CD86 (P = 0.00000024). Data shown are from one experiment  s.e.m.
(n = 5 mice per group), representative of a total of three independent experiments. Large-scale R:D45 hybrid synthesis was performed for each experiment, with
purity estimated by PAGE at 96%, 91%, and 98% hybrid, respectively.
B R:D45 complexed to Invivofectamine induces cytokine production in vivo. C57BL/6 mice were injected with R:D45 as described for (A). Serum levels of IL-6
(***P = 0.000526) and IFN-a (***P = 0.0000026) were determined 12 h post-injection. Data pooled from three independent experiments  s.e.m. (10–15 mice total
per condition).
C R:D45 induces cytokine production when transfected ex vivo in human PBMCs. Freshly isolated PBMCs were transfected with R:D45 complexed to Lipofectamine
LTX. Supernatant cytokine levels were quantified 18 h later by ELISA. Data pooled from two independent experiments  s.e.m., **P = 0.00166 (IL-6), ***P = 0.00011
(IFN-a) (7 donors in total).
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Figure 4. Detection of RNA:DNA hybrids requires MyD88 and TLR9.
A, B The cytokine response to R:D60 is absent in Myd88/Trif/ but not Ips-1/ mice. FLDCs derived from MyD88/;Trif/, Ips-1/ and wild-type (C57BL/6) control
mice were transfected with R:D60. Supernatant levels of IL-6 (A) and IFN-a (B) are represented as percentage of cytokine produced by C57BL/6 wild-type controls
included in each experiment. Data shown are the mean of three (Ips-1/) or two (Myd88/;Trif/) independent experiments  s.e.m. (one-sample t-test). ns
P = 0.9442 (IPS-1 IFN-a), **P = 0.0102 (MyD88/TRIF IFN-a), ns P = 0.5790 (IPS-1 IL6), *P = 0.0396 (MyD88/TRIF IL6).
C, D MyD88 is essential for cytokine secretion and phenotypic activation of FLDCs by R:D60. FLDCs derived from MyD88/ and C57BL/6 control mice were transfected
with R:D60. Supernatant cytokine levels (C) and surface expression of co-stimulatory molecules were determined 18 h post-transfection, with CD86 shown as
representative (D). Data shown are the mean of 2 independent experiments  s.e.m. (C) or  s.d. (D) (unpaired t-test). In (C), **P = 0.0015 (IL-6); *P = 0.0271
(IFN-a). In (D): ***P = 0.00072 (pDCs CD86); **P = 0.00444 (cDCs CD86).
E, F The cytokine response to R:D60 is significantly impaired in TLR9-deficient but not TLR7-deficient FLDCs. Cultures derived from Tlr9/, Tlr7/ and C57BL/6 mice
were transfected with R:D60/poly U, or stimulated by the addition of CpG ODN to the culture medium. Supernatant cytokine levels were determined by ELISA.
Levels of IL-6 and IFN-a3 are represented as percentage of cytokine produced by wild-type controls to the TLR9 ligand CpG ODN (E) or the TLR7 ligand poly U (F).
Data are the mean of six and three independent experiments  s.e.m., respectively. ***P = 0.0003 (Tlr9/ IL-6), *P = 0.0514 (Tlr9/ IFN-a), ns P = 0.3761 (Tlr7/
IL-6), ns P = 0.1224 (Tlr7/ IFN-a).
G R:D45-induced cytokine production is TLR9-dependent. FLDCs derived from Tlr9/ and C57BL/6 mice were transfected with R:D45 or poly U. Cytokine levels were
determined 18 h post-transfection. Phenotypic activation as determined by CD40/80/86 expression was also entirely TLR9-dependent. Data are representative of
two independent experiments  s.d. of duplicate samples.
H Cytokine production by both cDCs and pDCs in response to R:D60 is impaired in Tlr9-deficient FLDCs. Day 8-FLDC cultures were sorted into CD11c+ B220+ PDCA1+
(pDC) and CD11c+ B220 PDCA1 (cDC) populations and transfected with R:D60 or stimulated by the addition of CpG ODN. Data shown are representative of
three independent experiments  s.d. of replicate samples. *P = 0.0355 (cDCs, IL-6), *P = 0.0165 (pDCs, IFN-a).
I The cytokine response to R:D60 is sensitive to chloroquine treatment. FLDCs derived from C57BL/6 mice were treated with 10 lM chloroquine prior to stimulation
with R:D60 and CpG ODN as described for (H). Data shown are representative of three independent experiments  s.d. of replicate samples. **P = 0.0025 (IL-6),
*P = 0.0151 (IFN-a).
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with LysoTracker, a marker of acidified endolysosomes. Confocal
microscopy demonstrated that many Cy3/Cy5-labelled R:D45 foci
colocalised with LysoTracker (Fig 6E, Supplementary Fig S5),
establishing that liposomal mediated transfection delivers RNA:DNA
hybrids to the appropriate intracellular compartment where TLR9
sensing occurs.
TLR9 directly binds RNA:DNA hybrids with a high affinity
To determine whether TLR9 and R:D60 interact in the absence of
other factors and to quantify the affinity of the interaction, binding
of purified recombinant TLR9 to fluorescently labelled RNA:DNA
hybrid was assessed. Since the ectodomain of TLR9 is proteolyti-
cally cleaved by endosomal proteases to produce an active receptor
(Ewald et al, 2008; Park et al, 2008), the affinity of the C-terminal
proteolytic cleavage fragment of mouse TLR9 ectodomain (mTLR9-
cECD) for R:D60 was measured by fluorescence anisotropy polariza-
tion. The dissociation equilibrium constant (Kd) was determined by
titrating mTLR9-cECD into a solution of R:D60 labelled at the 5′ end of
the RNA strand with the cyanine Cy3 dye. R:D60 binding to mTLR9-
cECD was unexpectedly strong, with a Kd value of 0.027 lM (Fig 7A),
revealing an interaction approximately 25-fold stronger than between
mTLR9-cECD and prototypical single-stranded DNA TLR9 ligands (Li
et al, 2012). This was also stronger than a previously tested dsDNA
ligand (Li et al, 2012). Significantly, the affinity for the single-stranded
constituents of R:D60 was also much lower with Kd of 0.136 and
1.075 lM for ssDNA60 and ssRNA60 respectively (Fig 7B, C).
RNA:DNA hybrids accumulate in the cytosol and endosomes
during retroviral infection
Many pathogens, most notably retroviruses, generate RNA:DNA
hybrids as replication intermediates within an infected cell. To
establish if significant levels of intact RNA:DNA hybrids were present
within infected cells, we used the S9.6 antibody to affinity-purify
RNA:DNA hybrids from B3T3 fibroblasts infected with the retrovirus
Moloney Murine Leukaemia Virus (MMLV). Following S9.6 pull
down of RNA:DNA hybrids from cytoplasmic extracts of infected
cells, viral nucleic acid was detectable by PCR using virus-specific
primers (Fig 8A, B). As PCR detects both MMLV DNA and RNA:
DNA hybrids, the specificity of the S9.6 pulldown for RNA:DNA
hybrids was confirmed by pre-treatment with RNase H, which
abrogated the PCR signal, consistent with pull down of intact RNA:
DNA hybrids by the S9.6 antibody. Quantification by qPCR using
two different sets of primers showed that S9.6 immunoprecipitates
4.1  1.1% of MMLV cytoplasmic DNA (Fig 8B, P ≤ 0.03), demon-
strating that significant levels of intact RNA:DNA hybrids can accu-
mulate during viral infection. As detection of TLR9 ligands occurs
in endosomes, we next sought to determine if viral RNA:DNA
hybrids could be detected in the endosomes of infected cells.
Endosomal fractions were prepared from B3T3 cells infected with
MMLV by discontinuous sucrose gradient ultra-centrifugation and
validated by immunoblotting to confirm the presence of the endo-
some marker Rab5, and absence of GAPDH, a cytosolic enzyme,
from these fractions (Fig 8C). Subsequently, the S9.6 antibody was
used to pull down RNase H-sensitive nucleic acids from this
endosomal fraction (Fig 8D), consistent with the presence of viral
RNA:DNA hybrids in the endosomes of MMLV-infected cells.
In summary, RNA:DNA hybrids bind directly to TLR9 with high
affinity to activate the receptor and induce innate immune activation
in DCs, indicating that intracellular RNA:DNA hybrids containing
viral-related sequences are a novel class of immunostimulatory
nucleic acid ligand. Taken together with the detection of RNA:DNA
hybrids in endosomal fractions during a viral infection, these experi-
ments also support the notion that endosomal sensing of RNA:DNA
hybrids by TLR9 is physiologically relevant.
Discussion
The definition of nucleic acid ligands for the PRRs of the innate
immune system, such as di-cyclic GMP and 5′-triphosphate RNA,
has led to important insights into the intracellular sensing of micro-
bial pathogens over recent years (Myong et al, 2009; Schlee et al,
2009; Burdette et al, 2011). Here we report a novel nucleic acid
ligand, establishing for the first time that RNA:DNA hybrids are a
molecular pattern that induce a pro-inflammatory cytokine response
in dendritic cells. Unexpectedly, RNA:DNA hybrids are sensed by
TLR9, a PRR first characterised over a decade ago (Hemmi et al,
2000). Therefore, in addition to its established role in sensing unme-
thylated CpG-rich bacterial DNA, TLR9 also detects RNA-containing
nucleic acids, thereby extending the role this receptor could play in
viral sensing and systemic autoimmunity.
Previous studies of synthetic ligands for the cytosolic RNA heli-
case RIG-I have highlighted the importance of accurately defining
the biochemical nature of nucleic acid ligands (Myong et al, 2009;
Schlee et al, 2009). In our study, several lines of evidence permit us
to conclude that intact RNA:DNA hybrids are TLR9 ligands. Firstly,
our ligand is precisely defined, generated from chemically synthes-
ised HPLC-purified oligonucleotides, and its purity demonstrated by
PAGE and FPLC analysis. Secondly, robust activation of TLR9
requires the intact RNA:DNA hybrid, and this cannot be replicated
by the constituent single-stranded nucleic acids. Finally, RNA:DNA
hybrids directly bind the activated TLR9 receptor ectodomain with
high affinity (Fig 7), with a much lower Kd than either its constituent
single-stranded nucleic acid components, or known ssDNA
TLR9 ligands measured under the same assay conditions (Li et al,
2012).
RNA:DNA hybrids represent an additional type of nucleic acid
sensed by TLR9, distinct from the canonical unmethylated CpG-rich
single-stranded DNA ligand (Hemmi et al, 2000; Bauer et al, 2001).
However double-stranded DNA (dsDNA), the physiologically abun-
dant form of DNA, is also a TLR9 ligand (Cornelie et al, 2004;
Kindrachuk et al, 2007), therefore as duplex nucleic acids, hybrids
are also plausible ligands for this receptor. Likewise, although CpG
sequence motifs are classically associated with TLR9 binding
(Hemmi et al, 2000; Bauer et al, 2001), such specificity is dependent
on phosphorothiorate chemistry (Haas et al, 2008). This challenges
the widely held and attractive assumption that unmethylated CpG-
rich DNA is the natural TLR9 ligand, and so TLR9 activation by
RNA:DNA hybrids without CpG sequences is also in keeping with
existing literature. Furthermore, the phosphodiester backbone of the
RNA:DNA hybrids used in this study is of a greater physiological
relevance than CpG phosphorothiorate ODNs whose correspondence
to natural ligands is limited both by strandedness and backbone
structure.
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The R:D60 RNA:DNA hybrid is notably more immunostimulatory
than the corresponding ssDNA oligonucleotide at the same concen-
tration (Fig 5A–C). A weak cytokine response at this relatively low
concentration (25 nM) is in keeping with previous studies of
phosphodiester ssDNA oligonucleotides (Yasuda et al, 2006; Haas
et al, 2008), which demonstrated immunostimulation at higher
concentrations. The differential response observed here correlates
with the higher affinity of the TLR9 receptor for the hybrid (Fig 7),
therefore binding affinity may be important in determining cyto-
kine response. Other factors such as the relative stability of ssDNA
and RNA:DNA hybrids within the endosome could also play a role.
Future studies correlating the relative abundance and receptor
affinities of naturally occurring TLR9 ligands with cytokine response
may therefore be informative in defining which are most relevant
to disease.
As RNA:DNA hybrids are essential intermediates in the replica-
tion of most microbial pathogens, perhaps most notably in the retro-
viral life cycle (Hu & Hughes, 2012), their detection by the innate
immune system would be anticipated. Hybrid replication intermedi-
ates are also generated by DNA viruses (Pritchard et al 1998, Miller
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et al 1984) and so sensing of RNA:DNA hybrids could have broad
utility for viral defence. Although TLR7 is the major sensor for retro-
viruses via detecting the ssRNA genome during viral entry (Kane
et al, 2011; Lepelley et al, 2011), lentiviral replication intermediates
can also be proinflammatory (Doitsh et al, 2010). Reverse transcrip-
tion products containing RNA:DNA hybrids could be sensed by
TLR9, which has been implicated in pDC sensing of lentiviruses
(Mandl et al, 2008) and in suppressing endogenous retrovirus
(ERV)-induced diseases via the modulation of humoral antibody
responses (Yu et al, 2012).
It is conceivable that RNA:DNA hybrids could be delivered to
endosomal TLR9 upon viral entry, as reverse-transcribed nucleic
%
 o
f f
oc
i
R4
5:D
45
R4
5 +
 D
60
0
20
40
60
80
100CBA
Red or green foci
Yellow foci
RNA45 DNA45 S9.6 merge
mergeRNA45 DNA45 endolysosomes
*
R45:D45 R45 + D60
D E
E*
Figure 6. Intact RNA:DNA hybrids are detectable by immunofluorescence inside FLDCs.
Fluorescently labelled RNA and DNA strands of R:D45 remain equally colocalised in FLDCs following transfection, but non-complementary RNA and DNA oligonucleotides
do not.
A Confocal maximum projection image of a cell after transfection with fluorescently labelled R:D45, generated by annealing Cy5-labelled ssRNA45 and Cy3-labelled
ssDNA45 oligonucleotides. DNA visualised by DAPI, blue.
B Confocal image of a cell transfected with non-complementary Cy3-ssRNA45 and Cy5-ssDNA60 oligonucleotides.
C Quantification of nucleic acid foci in FLDCs transfected with either fluorescently labelled R:D45 (n = 50) or Cy3-ssRNA45 with Cy5-ssDNA60 (n = 118).
D Intracellular R:D45 is detected by the anti-RNA:DNA hybrid antibody S9.6. FLDCs were transfected with fluorescently labelled R:D45 as for (A), and fixed and
permeabilised prior to immunofluorescent detection with the S9.6 antibody. Representative maximum projection confocal image is shown. Scale bar, 2 lm.
E R:D45 frequently colocalises with the endolysosomal marker LysoTracker. Cells were transfected with fluorescently labelled R:D45 as for (A) then incubated with
LysoTracker for 1 h. Maximum projection image of a representative field of view. Scale bar, 10 lm.
E* Higher magnification image of a cell (*) in (E). Scale bar, 2 lm.
Figure 5. TLR9 is activated by intact RNA-DNA hybrids.
A, B The cytokine response (IL-6 (A), IFN-a (B)) of FLDCs to R:D60 is distinct from that of its single-stranded nucleic acid components. Day 8-FLDC cultures were FACS-
sorted into pDC and cDC populations and transfected with R:D60 or equimolar amounts of ssRNA60 and ssDNA60. Data shown are the mean of three
independent experiments  s.e.m.
C Cytokine induction by R:D60 but not ssRNA60 is TLR9-dependent. FLDCs derived from Tlr9/ and C57BL/6 mice were transfected as described for (A) and (B). Data
shown are from two independent experiments  s.d.
D, E The cytokine response of FLDCs to R:D60 is not due to immunostimulatory contaminants remaining after FPLC. Nucleic acid hybridisation reactions were
generated as outlined in Fig 1A omitting one of the two oligonucleotides and fractionated using identical FPLC conditions to those used to purify annealed
RNA:DNA hybrids. Upper panel: nucleic acids from mock hybridization reactions (minus ssRNA (D), minus ssDNA (E)) eluted later than the established elution
position of R:D60 (arrow). The fractions (12.9 ml – 13.7 ml) corresponding to those that would usually contain the hybrid (R:D fraction) and fractions containing
the nucleic acids at the indicated peaks, were concentrated by ethanol precipitation. Lower panels: 200 ng of FPLC-purified R:D60, 200 ng of hybridisation
reaction column input (labelled minus ssRNA and minus ssDNA respectively), along with equal volumes of each fraction, were analysed by native PAGE.
F Immunostimulatory contaminants are absent from the R:D60 fraction. FLDCs transfected with FPLC-purified R:D60 and the equivalent volume of R:D fractions
from the hybridisations shown in (D) and (E) using Lipofectamine 2000. Supernatant concentrations of IL-6 (upper panel) were quantified 18 h post-transfection
by ELISA and Ifna1 transcript levels (lower panel) normalised to Actb expression quantified 6 h post-transfection by qRT-PCR (fold mRNA induction from medium
alone samples). Data shown are the mean of three experiments  s.e.m. (IL-6, **P = 0.0028) and PCR triplicates  s.d. (Ifna1, **P = 0.0001).
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acids have been detected in retrovirions (Dornadula et al, 1999).
Alternatively, as viral replication products, they may be transported
through the endosomal pathway following autophagy (Lee et al,
2007). Most likely, death of virally infected cells with subsequent
phagocytosis by APCs could result in presentation of RNA:DNA
hybrids to TLR9. In this respect, it is of note that the complexing of
RNA:DNA hybrids to LL37 efficiently activated DCs (Fig 2F),
establishing at least one physiological mechanism by which hybrids
released by dying cells can be delivered intracellularly to DCs. LL-37
has been shown to enhance TLR3 signalling in response to viral dsR-
NAs that are poor agonists by themselves (Lai et al, 2011) and it can
also complex with self-DNA and self-RNA in autoimmune disorders,
altering internalisation and endosomal processing to induce inflam-
matory responses to otherwise non-immunogenic nucleic acids via
TLR7, TLR8 and TLR9 (Lande et al, 2007; Ganguly et al, 2009).
Systemically released RNA:DNA hybrids may likewise contribute
to autoimmunity, analogous to the established importance of circu-
lating DNA in SLE pathogenesis (Napirei et al, 2000; Yasutomo
et al, 2001). While exogenous DNA is cleared by DNase I (Napirei
et al, 2000), human serum lacks nuclease activity against RNA:DNA
hybrids (R.E.R., unpublished data), so hybrids could persist extra-
cellularly, thereby contributing to the activation of IFN-producing
pDCs in lupus (Ronnblom et al, 2003). Alternatively, cell-intrinsic
responses to self-RNA:DNA hybrids may result from the activation
of endogenous retroviruses. Cytoplasmic nucleic acids encoded by
retroelements accumulate in the Trex1/ mouse (Stetson et al,
2008) and result in systemic autoimmune disease (Gall et al, 2012).
As mutations in the genes encoding both TREX1 and the trimeric
RNase H2 complex cause autoinflammation in AGS (Crow et al,
2006a,b), it has been proposed that RNase H2-AGS results from the
failure to degrade the RNA:DNA intermediates of endogenous retro-
viruses (Stetson, 2009). Therefore, inappropriate activation of the
innate immune response by endogenous RNA:DNA hybrids could
be an important contributing factor in the pathogenesis of autoim-
mune disease (Supplementary Fig S7).
In conclusion, we demonstrate that RNA:DNA hybrids are novel
molecular pattern that induce a TLR9-dependant innate immune
response. This class of nucleic acids therefore warrants further inves-
tigation to establish its role in both autoimmunity and host response
to viral infection. The identity of naturally occurring TLR9 microbial
ligands has not yet been definitively established. Given that dsDNA
and RNA:DNA hybrids coexist alongside other nucleic acids during
pathogen infection, the precise nature of the substrates sensed by
TLR9 remains an open question and an interesting future challenge.
Materials and Methods
Reagents
CpG-ODN (Mouse ODN1585, Human ODN2216, both type A
CpG ODNs) were from Invivogen and poly U from Sigma Aldrich.
Oligonucleotides were synthesised by Eurogenetec and Sigma-
Genosys and purified by PAGE/HPLC.Murine recombinant Flt3-Lwas
from Peprotech. Murine Ifna1 and Il6 qRT-PCR primers were from
RealTimePrimers.com. LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLR
NLVPRTES) and scrambled LL-37: RSLEGTDRFPFVRLKNSRKLEFKDI
KGIKREQFVKIL) were custom synthesised by Almac (East Lothian,
Scotland) using Fmoc solid phase synthesis and reversed phase HPLC
purification. For each peptide, identity was confirmed by electrospray
mass spectrometry, purity (>95% area) by RP-HPLC and net peptide
content determined by amino acid analysis.
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Figure 7. TLR9 directly binds RNA:DNA hybrids.
A–C Equilibrium binding of the C-terminal proteolytic cleavage fragment of
mouse TLR9 ectodomain (mTLR9-cECD) to R:D60 measured by
fluorescence spectroscopy. The 3′ end of the RNA strand of R:D60 was
labelled with a Cy3 fluorophore for this experiment, and was at a
concentration of 200 nM (A). The binding curve was fitted as described
in the Materials and Methods giving a Kd value of 27.2 nM for mTLR9-
cECD binding to Cy3-R:D60. A control for non-specific binding using
bovine serum albumin instead of mTLR9-cECD showed no binding to
Cy3-labelled R:D60. Equilibrium binding of 5′ Cy5-labelled ssDNA60
(Kd = 142 nM) (B) and 5′ Cy3-labelled ssRNA60 to mTLR9-cECD
(Kd = 1075 nM) (C) were also quantified.
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Antibodies
Flow cytometry antibodies: B220/CD45R-e450, CD3-e780, CD11b-
APC, CD11c-e780, CD19-e780, CD49b-e780 CD86-Alexa Fluor 488,
NK1.1-e780 from eBioscience. CD8a-PECF594, CD40-PE from BD
Pharmingen. B220-BV650, CD11b-BV711, CD11c-BV421, CD40-
FITC, CD80-BV605, CD86-A700, F4/80-PE-Cy7, Ly6C-BV570, Ly6G-
APC-Cy7, MHC II-PerCP-Cy5.5 from Biolegend. PDCA-1-PE, FcR
block from Miltenyi Biotec. The S9.6 monoclonal antibody against
RNA:DNA hybrids was purified from hybridoma cell line HB-8730
(ATCC-LGC Promochem) supernatant using a Protein A/G column
as previously described (Pohjoismaki et al, 2010).
Generation and purification of RNA:DNA hybrids
PAGE/HPLC-purified RNA and DNA oligonucleotides were recon-
stituted to 100 lM with nuclease-free distilled water (Invitrogen).
RNA:DNA hybrids were formed using 20 lM of each comple-
mentary oligonucleotide denatured in 60 mM KCl, 50 mM Tris
(pH 8.0) at 95°C for 5 min followed by gradual cooling to room
temperature. Resulting RNA:DNA duplexes were concentrated by
precipitation with 2.5 volumes of 100% ethanol, 0.3 M sodium
acetate (pH 5.2) and resuspended in an appropriate volume of
nuclease-free TE (10 mM Tris, 0.1 mM EDTA). Purification was
performed on an €AKTA FPLCTM machine (GE Healthcare) at 4°C
by injecting 100 ll volume of nucleic acids onto a 24-ml Superdex
10/300 GL column (GE Healthcare) pre-equilibrated with two
column volumes of nuclease-free TE. Elution was performed with
equilibration buffer (TE) at a flow rate of 0.4 ml/min, with 100 ll
fractions collected into sterile nuclease-free 96-well 2-ml boxes
(Greiner Bio-One). Absorbance at 280 nm was recorded for each
fraction. Relevant fractions containing the purified hybrid were
pooled, quantified and concentrated by ethanol precipitation and
analysed by native PAGE.
Characterisation of RNA:DNA hybrids by PAGE
and immunoblotting
Size separation of nucleic acids under native conditions was
performed using 15% native PAGE gels, pre-run for 1 h at 5 W 4°C,
samples were loaded in an equal volume of native loading buffer
(30% (v/v) glycerol, 80 mM HEPES-KOH (pH 7.9), 100 mM KCl,
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Figure 8. Viral RNA:DNA hybrids accumulate in the cytoplasm and endosomes of MMLV infected cells.
A, B Viral RNA:DNA hybrids are present in the cytoplasm of MMLV infected cells. (A) MMLV-specific PCR detects RNA:DNA hybrids immunoprecipitated from cytoplasmic
nucleic acids. As PCR detects both MMLV DNA and RNA:DNA hybrids, specificity of the S9.6 pull down for hybrids is confirmed by the absence of PCR product in
control samples processed with either S9.6 antibody omitted or when cytoplasmic nucleic acids were pretreated with RNase H. Labels: H2O, PCR without template
added; Input, cytoplasmic nucleic acids prior to immunopreciptation (equal in proportion to post-pull down template); Uninfected, cytoplasmic nucleic acids from
uninfected B3T3 cells.
B Quantification of MMLV RNA:DNA hybrids immunoprecipitated by S9.6 by qPCR using two independent MMLV primer sets. S9.6 immunoprecipitate contains
4.1  1.1% of input molecules. RNase H treatment reduces the amount of MMLV-DNA pulled down by S9.6 by >90%. Data shown are the mean of three
independent IP/qPCR experiments  s.d. *P = 0.0366 (MMLV-1), *P = 0.231 (MMLV-2).
C Validation of endosomal fractionation: the early endosome marker Rab5 is enriched in endosomal preparations. Western blotting of cytoplasmic and endosomal
fractions shows the presence of the endosomal marker Rab5 in both endosomal and cytoplasmic fractions, whereas GAPDH is only present in cytoplasmic
fractions. Densitometry measurements show that relative Rab5 enrichment is > 22-fold relative to GAPDH.
D Viral RNA:DNA hybrids are present in endosomal fractions of MMLV-infected cells. MMLV DNA was detected by PCR after S9.6 pull-down of hybrids from
endosomal nucleic acids, but not in beads only or RNase H treated controls.
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2 mM magnesium acetate) and electrophoresed in 1× TBE at 5 W
4°C in a vertical gel tank (EV200, Cambridge Electrophoresis).
Nucleic acids were visualised using Sybr Gold (Invitrogen) according
to manufacturer’s instructions and imaged on a phosphorimager
(FLA-2000, Fujifilm) or UV transilluminator (BioDoc-It System,
UVP). Immunoblot detection of RNA:DNA hybrids was performed by
transfer of electrophoresed nucleic acids to Hybond-N+ (GE Health-
care) using a Trans-Blot Semi-Dry Electrophoretic Transfer Cell
(Bio-Rad Laboratories), in 1× TBE for 30 min at a maximum current
of 3 mA/cm2. Nucleic acids were cross-linked to the membrane by
exposure to 1200 mJ/cm2 UV (Stratalinker, Stratagene). Membrane
was pre-blocked overnight in 1% (w/v) blocking agent (GE Health-
care) in 0.1% (v/v) Tween-20/PBS at 4°C, washed in 0.1% (v/v)
Tween-20/PBS, probed with 200 ng/ml S9.6 antibody in 2% (w/v)
BSA/PBS overnight at 4°C, and then incubated with HRP-conjugated
goat anti-mouse IgG antibody (1:5,000, Dako Corporation) for
1 h at room temperature, followed by ECL detection (GE
Healthcare).
Preparation of bone marrow-derived Flt3-L dendritic cells
All mice used were on a C57BL/6J background, male and aged
8–14 weeks. Bone marrow was harvested from femurs and tibiae
and red blood cells lysed with 0.168 M NH4Cl (pH 7.2) before cul-
ture in RPMI 1640 (Sigma Aldrich) supplemented with 10% (v/v)
heat inactivated FCS, 2 mM L-glutamine, 50 lM b-mercaptoethanol,
100 U/ml penicillin, 100 lg/ml streptomycin and 200 ng/ml recom-
binant murine Flt3-L for 8 days. DCs were harvested by gentle rins-
ing with culture medium.
Isolation of human PBMCs
PBMCs were isolated from peripheral blood from adult donors using
Lymphoprep (Stemcell Technologies), according to the manufac-
turer’s instructions.
Cell stimulation with nucleic acids
Cells were seeded at 1 × 106 cells into 48-well plates in culture
medium without antibiotics and transfected with nucleic acids
using Lipofectamine LTX (Invitrogen) and OptiMEM (Invitrogen)
according to manufacturer’s instructions. 1 lg/ml of R:D60, R:D45
or poly U were used for transfection or 1 lg/ml CpG-ODN added to
the culture medium in a final volume of 500 ll/well and cells incu-
bated at 37°C for 18 h. Alternatively, 1 lg/ml R:D45 was complexed
with 25 lg/ml LL-37 or scrambled LL-37 peptide, before cell incuba-
tion as above. Supernatants for ELISAs were harvested, centrifuged
at 1500 g for 5 min at 4°C and stored at 80°C. Cells were stained
for analysis by flow cytometry or analysis of gene expression by
qRT-PCR.
Flow cytometry
Samples were acquired using FACS LSR II and FACS Canto II using
BD FACSDiva software and analyzed with FlowJo v.9 software
(Tree Star). FLDC subsets were sorted using a FACS Aria II (BD Bio-
sciences) following staining with CD11c, B220 and PDCA-1 antibod-
ies. Post-FACS sorting purity of each population was > 95%.
ELISAs
Murine IL-6 and TNF-a and human IL-6 were quantified using Duoset
Kits (R&D Systems) and human IFN-a using an IFN-a pan specific
ELISA kit (Mabtech). Murine IFN-a was determined using 96-well
microtitre plates (Nunc) coated with monoclonal rat anti-mouse IFN-
a (clone RMMA-1, PBL Interferon Source) at 910 ng/ml overnight at
room temperature. After blocking with 5% (w/v) BSA/PBS for 1 h at
room temperature, 50 ll of supernatant sample was added overnight
at 4°C, and detected with polyclonal rabbit anti-mouse IFN-a (PBL
Interferon Source) at 80 ng/ml for 2 h, HRP-conjugated donkey anti-
rabbit (Jackson ImmunoResearch Laboratories) at 80 ng/ml for 1 h,
and BM Blue POD substrate (Roche). Recombinant mouse IFN-a3
(PBL Interferon Source) was included as a standard.
Analysis of gene expression by qRT-PCR
RNA was extracted from cells using an RNeasy Mini kit (Qiagen)
with on-column DNase I treatment. For 1st strand cDNA synthesis,
1 lg RNA, 40 U Protector RNase Inhibitor (Roche), 100 pmol ran-
dom primers (Promega), 5 mM RNase-free DTT in 14 ll was incu-
bated at 70°C for 5 min, cooled on ice for 5 min before the addition
of 1 lM dNTPs (Invitrogen), 20 U AMV Reverse Transcriptase
(Roche), 1× AMV Reverse Transcriptase buffer in 20 ll with incuba-
tion at 42°C for 1 h, 75°C for 8 min. For qRT-PCR, reactions containing
1 ll of cDNA, 1× Brilliant II Sybr Green qPCR Master Mix (Strata-
gene), 0.3 lM passive reference dye (ROX) and 0.2 lM of each
primer in a 10 ll volume were amplified in an ABI Prism HT7900
Sequence Detection System (Applied Biosciences), for 2 min at 50°C,
10 min at 95°C followed by 40 cycles of 15 s at 95°C, 1 min at 60°C.
Expression of each target gene was normalised to Actb (b-actin)
using the comparative CT method (Livak & Schmittgen, 2001).
Immunofluoresence
Day 8 FLDCs from C57BL/6 mice were transfected with 1 lg/ml
fluorescently labelled R:D45 or the fluorescently labelled non-
complementary oligonucleotides ssRNA45 and ssDNA60 using
Lipofectamine LTX. After 1 h, cells were adhered to polysine slides
(Thermo Scientific), fixed with 4% PFA and nuclei stained with
DAPI. To stain endolysosomal compartments, 2 lM LysoTracker
Green DND-26 (Life Technologies) was added to the cells for 1 h
before fixation. To visualise RNA:DNA hybrids using the S9.6 anti-
body, fixed cells were permeabilised using 0.2% (v/v) Triton X-100/
PBS for 2 min, blocked for 1 h with 2% (w/v) BSA/PBS and incu-
bated with 1 lg/ml S9.6 antibody, which was detected using 1:500
dilution FITC-conjugated goat anti-mouse IgG (Molecular Probes).
Images were taken on a Nikon A1R confocal microscope comprising
of a Nikon Eclipse TiE inverted microscope with Perfect Focus
System. Image capture was performed using Nikon Nis-Elements C
(Nikon Instruments Europe). 3 channel images were acquired by
consecutive scanning with only one laser line active per scan.
In vivo studies of RNA:DNA hybrid response
Female age-matched C57BL/6J mice received a 200 ll intraperito-
neal injection of PBS alone, 80 lg R:D45 diluted in PBS or 80 lg
R:D45 (or sterile water as a control) complexed to Invivofectamine
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as per manufacturer’s instructions and further diluted to the
required concentration in PBS. 12 h post-injection, spleens were
harvested and serum samples were collected. Spleens were digested
at 37°C (with tilting and shaking) for 20 min with 0.4 U/ml Liberase
TL (Roche) and 80 U/ml DNase I type IV (Sigma-Aldrich). Single-
cell suspensions were prepared by mechanically disruption through
a 70-lm cell strainer. Red blood cell lysis was performed on the
single-cell suspension and these cells prepared for flow analysis of
phenotypic activation of DC populations. Dead cells were
excluded by staining with LIVE/DEAD Fixable Aqua Dead Cell Stain
(Invitrogen). Live-singlet lineage-negative (CD3, CD19, CD49b,
Ly6G, NK1.1) CD11chi B220 cells were gated as cDCs, whilst
CD11cmid B220+ PDCA-1+ Ly6C+ cells were defined as pDCs.
Inflammatory monocytes (CD11b+, Ly6C+) and macrophages
(CD11b+, F4/80hi) were excluded from this analysis.
Expression and purification of truncated TLR9 ectodomain
The truncated C-terminal ectodomain fragment of mouse TLR9
(mTLR9-cECD) was expressed in a baculovirus-insect cell system
and purified as described previously (Li et al, 2012). Briefly, a gene
encoding the proteolytically processed fragment (residues 474–824)
mTLR9-cECD with an N-terminal eight-histidine purification tag, fol-
lowed by the linker sequence Ser-Ser-Gly and a tobacco etch virus
protease cleavage site, was cloned into the pAcGP67-A vector (BD
Biosciences) in frame with the baculovirus gp67 signal sequence.
mTLR9-cECD was expressed in Tni insect cells (Expression Sys-
tems). Cells were infected with 1% (v/v) of third-passage baculovi-
rus stock. After culture in suspension for 72 h at 27°C mTLR9-cECD
was extracted from intracellular compartments with 50 mM Tris pH
7.5, 500 mM NaCl, 10% glycerol, 5 mM b-mercaptoethanol, 1%
Fos-Choline 12. mTLR9-cECD was purified by nickel affinity chro-
matography with a HisTrap HP column (GE Healthcare), followed
by cation exchange chromatography with a MonoS column (GE
Healthcare) and size-exclusion chromatography with a Superdex
200 10/300 GL column (GE Healthcare). The size-exclusion buffer
was 20 mM MES pH 5.6, 100 mM NaCl, 2 mM b-mercaptoethanol.
Fluorescence anisotropy polarization binding measurements
To determine the binding affinities of R:D60, ssRNA60 and
ssDNA60, mTLR9-cECD was titrated from a 0.2 mM stock solution
into a 0.2 lM solution of 3′ Cy3-labeled R:D60 for final mTLR9-
cECD concentrations between 10 nM and 3.0 lM in 20 mM MES pH
5.6, 100 mM NaCl, 2 mM b-mercaptoethanol. Binding studies were
performed at 25°C. The fluorescence anisotropy depolarization was
recorded after 10 min equilibration with a PTI Quantamaster C-61
two-channel fluorescence spectrophotometer. The TAMRA fluoro-
phore was excited at 550 nm and the emission was recorded at
570 nm, with a 6-nm slit width. Fluorescence anisotropy was deter-
mined as described (Grove et al, 2010). The binding constant of
mTLR9-cECD was determined with Origin 7 (OriginLab) by fitting
the data to equation 1 (Inglese et al, 1989):
STot ¼ SL þ ðSEL  SLÞ
ðKd þ ½LT þ ½ETÞ 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðKd þ ½LT þ ½ETÞ2  4½LT½ET
q
2½LT
6664
7775 (1)
where STot is the signal (fluorescence intensity or fluorescence
anisotropy) of ODN at protein concentration [E]T; SL is the signal
of labeled ODN, L; SEL is the signal of ODN in the plateau region
of the binding curve; [L]T is the total concentration of ODN added;
Kd is the dissociation constant. The data were initially fit to three
parameters [L]T, SEL and Kd using the measured values for SL, STol
and [E]T. The overall fit was selected such that the values for [L]T
and SEL coincided with the measured values for these parameters.
Detection of MMLV RNA:DNA hybrids
B3T3 mouse fibroblast cells were transfected with pNCS (Yueh &
Goff, 2003) (kindly provided by George Kassiotis) and passaged
12–15 times to allow the cells to accumulate a high viral load of
Moloney Murine Leukemia Virus (MMLV, encoded by pNCS).
Untransfected control cells were cultured in parallel. Cytoplasmic
nucleic acids (NA) were extracted from cells by resuspending in
1 ml of cytoplasmic buffer (20 mM Tris–HCl pH 7.5, 10 mM KCl,
10 mM EDTA, 10% (w/v) glycerol, 0.1% (v/v) Triton X-100) and
incubating on ice for 5 min. Nuclei were removed by 15 min centri-
fugation at 1,000 g 4°C, and heavy organelles by subsequent centri-
fugation for 15 min at 10,000 g 4°C. NA were extracted from the
remaining supernatant by the addition of 0.5% SDS followed by two
extractions with phenol:chloroform:isoamylalcohol (25:24:1) and
one with chloroform, and precipitated with an equal volume of iso-
propanol. NA was similarly isolated from cytoplasmic (post-nuclear
supernatants, PNS) and endosomal fractions (see below). RNA:DNA
hybrids were immunoprecipitated using the S9.6 antibody. Approxi-
mately 16 lg of S9.6 antibody was incubated with 30 ll of Dynabeads
Protein G (Life Technologies) and washed before incubation in
10 mM EDTA/PBS for 3 h at 4°C with 2 lg of cytoplasmic or
endosomal NA. As a proof of principle control to show that S9.6
pulls down RNA:DNA hybrids from solution, 10 pmol of R:D45
was used (Supplementary Fig S6). In further control reactions, NA
were incubated with Dynabeads Protein G only (i.e. no S9.6) or
treated with 10 U RNase H (NEB) for 1 h at 37°C before incubation
with Dynabeads Protein G (with bound S9.6). After thorough wash-
ing, bound NA were eluted in 0.6% SDS/10 mM EDTA, and both
unbound and bound fractions were ethanol precipitated. MMLV
DNA was subsequently detected using PCR and two different primer
sets (MMLV-1 and MMLV-2, Supplementary Table S1) amplifying
75- and 104-bp fragments of the viral genome, respectively. For stan-
dard PCR FastStart PCR Master (Roche) was used for 10 ll reactions
(5 min 95°C, then 35 cycles of 30 s 95°C, 30 s 60°C, 10 s 72°C) with
0.5 ll of input NA. For qPCR, 10 ll reactions containing 1 ll of input
NA, 1× Brilliant II Sybr Green qPCR Master Mix (Stratagene), 0.3 lM
passive reference dye (ROX) and 0.2 lM of each primer were ampli-
fied in an ABI Prism HT7900 Sequence Detection System (Applied
Biosciences), for 2 min at 50°C, 10 min at 95°C followed by 40 cycles
of 15 s at 95°C, 1 min at 60°C. Relative levels were calculated using
the comparative CT method (Livak & Schmittgen, 2001).
Endosome isolation
Endosomal isolations (mixture of early and late endosomes) were
performed by density gradient centrifugation as previously described,
with minor modifications (de Araujo et al, 2008). Solutions were pre-
pared as described above, but 10 mM EDTA was used and no
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protease or phosphatase inhibitors. Between 4 and 8 T75 flasks of
MMLV infected B3T3 were collected and lysed using hypotonic shock
in homogenisation buffer A followed by mechanical disruption by
passing the cell suspension through a 23-G needle six times. The post-
nuclear supernatant (PNS) was brought up to 42% sucrose and used in
discontinuous sucrose gradient centrifugation (42%, 35% and 8%) in
SW41 tubes for 3 h at 210,000 g 4°C. Endosomes were collected in
0.5–1 ml from the interface between 35% and 8% sucrose layers, and
used for Western blotting and NA isolation. For Western blotting,
10 lg of total PNS protein and 30 ll of the endosomal fraction were
separated on 4–12%NuPAGE (Life Technologies), transferred to PVDF
membrane, blocked in 1× TBST with 5% milk and probed with
anti-Rab5 antibody (Cell Signaling, 1:1,000 rabbit monoclonal C8B1)
and anti-GAPDH (Abcam, 1:1,000 HRP-conjugated ab39385)
respectively.
Statistical testing
Unpaired Student’s t-tests were performed unless otherwise stated,
calculated using GraphPad Prism Software version 6.0 (La Jolla,
USA). Significance levels are denoted in figures as: *P ≤ 0.05,
**P ≤ 0.01, ***P ≤ 0.001, ns not significant.
Supplementary information for this article is available online:
http://emboj.embopress.org
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